We are live on ! Find out more
GW

GW & Wade Portfolio holdings

AUM $3.08B
1-Year Est. Return 18.99%
This Fund
S&P 500
This Quarter Est. Return
+3.4%
1 Year Est. Return
+18.99%
3 Year Est. Return
+32.19%
5 Year Est. Return
+95.75%
10 Year Est. Return
+162.41%
AUM
$1.1B
AUM Growth
+$42.2M
Cap. Flow
+$12.2M
Cap. Flow %
1.11%
Top 10 Hldgs %
33.6%
Holding
243
New
14
Increased
122
Reduced
64
Closed
9

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$10.2M
2
MDT icon
Medtronic
MDT
+$8.87M
3
SO icon
Southern Company
SO
+$5.12M
4
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$3.51M
5
WMT icon
Walmart Inc
WMT
+$2.33M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$10.3M
2
CCI icon
Crown Castle
CCI
+$8.95M
3
AMGN icon
Amgen
AMGN
+$4.4M
4
VOD icon
Vodafone
VOD
+$2.5M
5
TRV icon
Travelers Companies
TRV
+$2.08M

Sector Composition

Rank Sector Weight
1 Technology 11.55%
2 Industrials 8.04%
3 Energy 7.64%
4 Consumer Staples 7.19%
5 Healthcare 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DLR icon
201
Digital Realty Trust
DLR
$73.7B
$270K 0.02%
2,289
+4
+0.2% +$476
EPD icon
202
Enterprise Products Partners
EPD
$83.8B
$265K 0.02%
9,193
– –
ROST icon
203
Ross Stores
ROST
$76.6B
$263K 0.02%
2,651
-169
-6% -$16.5K
NSP icon
204
Insperity
NSP
$1.85B
$255K 0.02%
+2,092
New +$252K
AXON
205
Axon Enterprise
AXON
$40.5B
$246K 0.02%
3,835
– –
XLV icon
206
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$242K 0.02%
2,615
– –
AFL icon
207
Aflac
AFL
$63.9B
$238K 0.02%
+4,349
New +$224K
XLC icon
208
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$238K 0.02%
+4,834
New +$235K
SDY icon
209
State Street SPDR S&P Dividend ETF
SDY
$21.9B
$237K 0.02%
2,346
+3
+0.1% +$300
UNH icon
210
UnitedHealth
UNH
$382B
$235K 0.02%
962
-5
-0.5% -$1.2K
HRC
211
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$234K 0.02%
+2,235
New +$226K
ABMD
212
DELISTED
Abiomed Inc
ABMD
$230K 0.02%
883
– –
NSC icon
213
Norfolk Southern
NSC
$78.8B
$229K 0.02%
1,150
-2,230
-66% -$442K
EEM icon
214
iShares MSCI Emerging Markets ETF
EEM
$28B
$227K 0.02%
5,299
– –
AIVI icon
215
WisdomTree International AI Enhanced Value Fund
AIVI
$60.2M
$217K 0.02%
5,280
– –
APD icon
216
Air Products & Chemicals
APD
$66.3B
$217K 0.02%
+957
New +$198K
RDS.A
217
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$215K 0.02%
3,311
-174
-5% -$11.1K
DD icon
218
DuPont de Nemours
DD
$18.6B
$214K 0.02%
2,269
-1,102
-33% -$132K
D icon
219
Dominion Energy
D
$62.5B
$213K 0.02%
2,756
– –
PSX icon
220
Phillips 66
PSX
$82.9B
$210K 0.02%
2,241
+11
+0.5% +$987
XEL icon
221
Xcel Energy
XEL
$51B
$209K 0.02%
+3,508
New +$202K
TXN icon
222
Texas Instruments
TXN
$255B
$205K 0.02%
1,785
-1,259
-41% -$141K
IXJ icon
223
iShares Global Healthcare ETF
IXJ
$4.11B
$204K 0.02%
3,310
– –
TY icon
224
TRI-Continental Corp
TY
$1.86B
$203K 0.02%
+7,521
New +$201K
BF.A icon
225
Brown-Forman Class A
BF.A
$12.3B
$202K 0.02%
+3,664
New +$192K
6 7 8
9
10

Similar funds

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

GW & Wade's Q2 2019 Portfolio in Review

As of Q2 2019, GW & Wade held 243 positions worth $1.1B, up 4% from $1.06B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

GW & Wade's Q2 2019 filing shows 14 new, 122 increased, 64 reduced and 9 closed positions. Its largest new stake was GSK: 15,322 shares worth $767K. The largest sale was 3M, an estimated $10.3M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Industrials and Energy.

  • GW & Wade's largest Q2 2019 buy was GSK: 15,322 shares worth $767K.
  • GW & Wade added most to Pfizer in Q2 2019, an estimated $10.2M increase.
  • GW & Wade's biggest Q2 2019 reduction was 3M, cutting an estimated $10.3M.
  • GW & Wade fully exited Crown Castle in Q2 2019, selling an estimated $8.95M.
  • GW & Wade's ten largest holdings make up 34% of its $1.1B portfolio in Q2 2019.
  • GW & Wade opened 14 new positions and closed 9 in Q2 2019.
  • GW & Wade's portfolio value rose 4% quarter-over-quarter to $1.1B.

Based on GW & Wade's 13F filing for Q2 2019, filed 12 Aug 2019.